Drug Information

Drug General Information
Drug ID
D0M9DC
Former ID
DAP000622
Drug Name
Oxaprozin
Synonyms
Actirin; Alvo; Danoprox; Daypro; Dayrun; Deflam; Oxaprozina; Oxaprozine; Oxaprozinum; Voir; Xopane; Apotex brand of oxaprozin; CSC brand of oxaprozin; Pfizer brand of oxaprozin; Rhoxalpharma brand of oxaprozin; TRB brand of oxaprozin; Lyl)propenoic acid; NCI310839; O 9637; WY 21743; Apo-Oxaprozin; Daypro (TN); Duraprox (TN); Oxaprozina [INN-Spanish]; Oxaprozine [INN-French]; Oxaprozinum [INN-Latin]; Rhoxal-oxaprozin; WY-21743; WY-21,743; Oxaprozin (JP15/USAN/INN); Oxaprozin [USAN:BAN:INN:JAN]; Beta-(4,5-Diphenyloxazol-2-yl)propionic acid; 3-(4, 5-Diphenyl-2-oxazo; 3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoic acid; 3-(4,5-Diphenyl-2-oxazolyl)propenoic acid; 4, 5-Diphenyl-2-oxazolepropionic acid; 4,5-Diphenyl-2-oxazolepropanoic acid; 4,5-Diphenyl-2-oxazolepropionic acid
Drug Type
Small molecular drug
Indication Rheumatoid arthritis [ICD9: 710-719, 714; ICD10:M05-M06] Approved [551871]
Therapeutic Class
Antiinflammatory Agents
Company
Gd Searle Llc
Structure
Download
2D MOL

3D MOL
Formula
C18H15NO3
InChI
InChI=1S/C18H15NO3/c20-16(21)12-11-15-19-17(13-7-3-1-4-8-13)18(22-15)14-9-5-2-6-10-14/h1-10H,11-12H2,(H,20,21)
InChIKey
OFPXSFXSNFPTHF-UHFFFAOYSA-N
CAS Number
CAS 21256-18-8
PubChem Compound ID
4614
PubChem Substance ID
9561, 224921, 455291, 3159337, 4254158, 7434787, 7847529, 7980214, 8141108, 8152831, 10320082, 11110656, 11110657, 11372015, 11374860, 11387071, 11407074, 11458222, 11460192, 11467088, 11468208, 11485388, 11486676, 11489512, 11490893, 11493045, 12013314, 14922602, 17405502, 24278617, 26534590, 26612863, 26652602, 26680054, 26719634, 26747622, 26747623, 29223703, 46386783, 46506429, 47216866, 47365302, 47515409, 47589083, 47810846, 47959863, 48185086, 49681726, 49699271, 50001218
SuperDrug ATC ID
M01AE12
SuperDrug CAS ID
cas=021256188
Target and Pathway
Target(s) Cyclooxygenase Target Info Inhibitor [536391]
References
Ref 551871Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
Ref 536391The aryl propionic acid R-flurbiprofen selectively induces p75NTR-dependent decreased survival of prostate tumor cells. Cancer Res. 2007 Apr 1;67(7):3254-62.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.